These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18257035)

  • 41. The case of Mr. A.B.
    Sloane P; DeRenzo EG
    J Clin Ethics; 2007; 18(4):399-401; discussion 402-3. PubMed ID: 18321003
    [No Abstract]   [Full Text] [Related]  

  • 42. Issues in disclosing a diagnosis of dementia.
    Cornett PF; Hall JR
    Arch Clin Neuropsychol; 2008 May; 23(3):251-6. PubMed ID: 18299184
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The ethics of routine use of advanced diagnostic technology.
    Khelemsky R
    J Am Coll Dent; 2011; 78(4):35-9. PubMed ID: 22416617
    [No Abstract]   [Full Text] [Related]  

  • 44. Placebo research and the spirit of informed consent.
    Miller FG; Wendler D
    Psychosom Med; 2005; 67(4):678; author reply 678. PubMed ID: 16046388
    [No Abstract]   [Full Text] [Related]  

  • 45. Respecting autonomy without disclosing information.
    Walker T
    Bioethics; 2013 Sep; 27(7):388-94. PubMed ID: 22486227
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of unconscious conflict in informed consent.
    Zeichner B
    Bull Am Acad Psychiatry Law; 1985; 13(3):283-90. PubMed ID: 4041635
    [No Abstract]   [Full Text] [Related]  

  • 47. Is informed consent not applicable in China? Intellectual flaws of the "cultural difference argument".
    Nie JB
    Taiwan Yi Xue Ren Wen Xue Kan; 2001 Oct; 2(1-2):67-74. PubMed ID: 15011657
    [No Abstract]   [Full Text] [Related]  

  • 48. A freedom to choose. The ethics of informed consent.
    Kendrick K
    Prof Nurse; 1994 Aug; 9(11):739-42. PubMed ID: 7972191
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The nocebo effect of informed consent.
    Cohen S
    Bioethics; 2014 Mar; 28(3):147-54. PubMed ID: 22762392
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Problems related to personal autonomy and informed consent.
    Weil WB
    Del Med J; 1987 Mar; 59(3):189-94, 199-203. PubMed ID: 3569613
    [No Abstract]   [Full Text] [Related]  

  • 51. Truth: treatment of choice, scarce resource, or patient's right?
    Gadow S
    J Fam Pract; 1981 Nov; 13(6):857-60. PubMed ID: 7310342
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disclosure of adverse clinical trial results--should legal immunity be granted to drug companies?
    Vernillo A
    Am J Bioeth; 2009 Aug; 9(8):45-7. PubMed ID: 19998162
    [No Abstract]   [Full Text] [Related]  

  • 53. Voluntary consent, normativity, and authenticity.
    Berghmans R
    Am J Bioeth; 2011 Aug; 11(8):23-4. PubMed ID: 21806432
    [No Abstract]   [Full Text] [Related]  

  • 54. When should the patient know?
    Veatch RM
    Barrister; 1981; 8(1):7-8+. PubMed ID: 11661996
    [No Abstract]   [Full Text] [Related]  

  • 55. Clarifying the nocebo effect and its ethical implications.
    Miller FG
    Am J Bioeth; 2012; 12(3):30-1. PubMed ID: 22416746
    [No Abstract]   [Full Text] [Related]  

  • 56. Disclosing rationing decisions: a reply to Paul S. Appelbaum.
    Hall MA
    Milbank Q; 1994; 72(2):211-5. PubMed ID: 8007896
    [No Abstract]   [Full Text] [Related]  

  • 57. The duty to disclose (even more) adverse clinical trial results.
    Hassoun N
    Am J Bioeth; 2009 Aug; 9(8):33-4. PubMed ID: 19998155
    [No Abstract]   [Full Text] [Related]  

  • 58. Regarding "Consent for residents to perform surgery".
    Kouchoukos NT
    J Vasc Surg; 2003 Apr; 37(4):918; author reply 918-9. PubMed ID: 12664007
    [No Abstract]   [Full Text] [Related]  

  • 59. What we learned about voluntariness and consent: incorporating "background situations" and understanding into analyses.
    Kamuya D; Marsh V; Molyneux S
    Am J Bioeth; 2011 Aug; 11(8):31-3. PubMed ID: 21806436
    [No Abstract]   [Full Text] [Related]  

  • 60. Response to the open peer commentaries on "Is there an ethical obligation to disclose controversial risk? A question from the ACCORD Trial".
    DeMarco JP; Ford PJ; Patton DJ; Stewart DO
    Am J Bioeth; 2014; 14(4):W1-2. PubMed ID: 24730505
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.